These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6013844)

  • 1. [Binding of some sulfanilamides to blood proteins of man. 1. Determinations of low sulfanilamide concentrations in vitro at room temperature].
    Spring P
    Arzneimittelforschung; 1966 Mar; 16(3):346-54. PubMed ID: 6013844
    [No Abstract]   [Full Text] [Related]  

  • 2. Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations.
    Tuomisto J; Saris NE
    Ann Med Exp Biol Fenn; 1970; 48(1):38-48. PubMed ID: 5419724
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of disease, drugs, and dilution on the binding of sulfonamides in human plasma.
    Anton AH
    Clin Pharmacol Ther; 1968; 9(5):561-7. PubMed ID: 5676798
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of the distribution of long-acting sulfanilamides in purulent pyelonephritis in rats].
    Rudzit EA; Ostapchuk NV; Bobrov VI
    Antibiotiki; 1983 Nov; 28(11):837-41. PubMed ID: 6651273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and binding of N-(2-methyl-6-methoxy-4-pyrimidinyl) sulfanilamide (sulfamethomidine) in man.
    DICARLO FJ; MALAMENT SG; HAYNES LJ; PHILLIPS GE
    Toxicol Appl Pharmacol; 1963 Jan; 5():61-70. PubMed ID: 14027680
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species.
    Berneis K; Boguth W
    Chemotherapy; 1976; 22(6):390-409. PubMed ID: 954483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Biochem Pharmacol; 1981 Dec; 30(24):3347-54. PubMed ID: 7326045
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the protein-binding of long-acting sulfonamides].
    SCHOLTAN W
    Chemotherapia (Basel); 1963; 6():180-95. PubMed ID: 13992327
    [No Abstract]   [Full Text] [Related]  

  • 9. [SULFONAMIDES].
    BOERGER HH
    Ther Ggw; 1963 Sep; 102():1037-44. PubMed ID: 14057434
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled study of 3 sulfonamides in chronic urinary and bronchial infections].
    Piolino M; de Kalbermatten JP; Dobjanski S; Granato D; Schelling JL
    Schweiz Med Wochenschr; 1968 Nov; 98(44):1756-62. PubMed ID: 4884544
    [No Abstract]   [Full Text] [Related]  

  • 11. [METABOLIC FATE OF DELAYED-ACTION SULFONAMIDES].
    SALVI G; PLANCHER AC
    Farmaco Prat; 1964 Feb; 19():75-83. PubMed ID: 14138309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of acetylsalicylic acid on sulfalene and sulfadimethoxine binding by serum proteins and on their kinetics in rabbits].
    Bobrov VI; Beletskaia GT; Nazarova OI; Iakovlev VP
    Antibiotiki; 1984 Mar; 29(3):220-3. PubMed ID: 6732209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CERTAIN MICROBIOLOGICAL PECULIARITIES OF NEW SULFANILAMIDES].
    KUTZSCHE A
    Chemotherapia (Basel); 1964; 64():53-62. PubMed ID: 14178045
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.
    Rieder J
    Chemotherapy; 1972; 17(1):1-21. PubMed ID: 5009465
    [No Abstract]   [Full Text] [Related]  

  • 15. BINDING CAPABILITY OF VARIOUS SULFONAMIDES TO SERUMS OF DIFFERENT ANIMAL SPECIES.
    GENAZZANI E; PAGNINI G
    Am J Vet Res; 1963 Nov; 24():1212-6. PubMed ID: 14081457
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.
    Anton AH
    Ann N Y Acad Sci; 1973 Nov; 226():273-92. PubMed ID: 4588442
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interactions of sulfanilamides, penicillins and acetylsalicylic acid in serum protein binding].
    Bobrov VI; Nazarova OI; Beletskaia GT; Agapitova IV; Iakovlev VP
    Antibiot Khimioter; 1988 May; 33(5):355-9. PubMed ID: 3415391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood levels of sulfamethoxy-pyridazine, sulfapyrazinemethoxyne, and sulfamethazine in swine.
    FAUSTINI R; VAGHI MA
    Am J Vet Res; 1962 Jan; 23():65-9. PubMed ID: 13891827
    [No Abstract]   [Full Text] [Related]  

  • 19. TREATMENT OF NON-GONOCOCCAL URETHRITIS FROM THE POINT OF VIEW OF EFFICIENCY AND COST: STREPTOMYCIN WITH LONG-ACTING SULPHONAMIDES.
    JELINEK G
    Br J Vener Dis; 1964 Dec; 40(4):268-9. PubMed ID: 14243825
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physicochemical and biological studies on sulfonamides. 2. Protein-binding, pharmacokinetics and distribution of 5 sulfonamides in rabbits].
    RIEDER J
    Arzneimittelforschung; 1963 Feb; 13():89-95. PubMed ID: 13982262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.